医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
20期
106-106
,共1页
下呼吸道%铜绿假单胞菌%耐药性%敏感%抗菌素
下呼吸道%銅綠假單胞菌%耐藥性%敏感%抗菌素
하호흡도%동록가단포균%내약성%민감%항균소
Lower respiratory tract%Pseudomonas aeruginosa%Drug resistance%Sensitive%Antibiotics
目的分析下呼吸道铜绿假单胞菌耐药性,为加强医院感染控制提供一定的学术依据。方法对2013年2月~11月我院送检的痰液标本进行抽样分析,从中分离到102株铜绿假单胞菌,用采用phoenix100细菌检测仪进行分析。并进行药敏实验,对铜绿假单胞菌的耐药性进行分析。结果铜绿假单胞菌的菌株数为102株,占16.92%,是检出率最高的菌株类型。铜绿假单胞菌对头孢曲松、氨苄西林、氨苄西林/舒巴坦的耐药性均为100%,耐药性最高。对阿米卡星、庆大霉素、妥布霉素的耐药性较低,其中对阿米卡星的耐药性为0。结论我院的铜绿假单胞菌的耐药性较高,这对临床治疗提供了生物学的参考,也为抗菌药物在医院临床上的使用提出了新的要求,提示今后应加强对铜绿假单胞菌的监测,进一步加强医院的感染控制措施。
目的分析下呼吸道銅綠假單胞菌耐藥性,為加彊醫院感染控製提供一定的學術依據。方法對2013年2月~11月我院送檢的痰液標本進行抽樣分析,從中分離到102株銅綠假單胞菌,用採用phoenix100細菌檢測儀進行分析。併進行藥敏實驗,對銅綠假單胞菌的耐藥性進行分析。結果銅綠假單胞菌的菌株數為102株,佔16.92%,是檢齣率最高的菌株類型。銅綠假單胞菌對頭孢麯鬆、氨芐西林、氨芐西林/舒巴坦的耐藥性均為100%,耐藥性最高。對阿米卡星、慶大黴素、妥佈黴素的耐藥性較低,其中對阿米卡星的耐藥性為0。結論我院的銅綠假單胞菌的耐藥性較高,這對臨床治療提供瞭生物學的參攷,也為抗菌藥物在醫院臨床上的使用提齣瞭新的要求,提示今後應加彊對銅綠假單胞菌的鑑測,進一步加彊醫院的感染控製措施。
목적분석하호흡도동록가단포균내약성,위가강의원감염공제제공일정적학술의거。방법대2013년2월~11월아원송검적담액표본진행추양분석,종중분리도102주동록가단포균,용채용phoenix100세균검측의진행분석。병진행약민실험,대동록가단포균적내약성진행분석。결과동록가단포균적균주수위102주,점16.92%,시검출솔최고적균주류형。동록가단포균대두포곡송、안변서림、안변서림/서파탄적내약성균위100%,내약성최고。대아미잡성、경대매소、타포매소적내약성교저,기중대아미잡성적내약성위0。결론아원적동록가단포균적내약성교고,저대림상치료제공료생물학적삼고,야위항균약물재의원림상상적사용제출료신적요구,제시금후응가강대동록가단포균적감측,진일보가강의원적감염공제조시。
Objective To analyze the resistance of Pseudomonas aeruginosa in lower respiratory tract ,in order to provides certain academic basis for strengthening the hospital infection control. Methods The sputum samples were analyzed in our hospital from February 2013 to November 2013, and 102 Pseudomonas aeruginosas were isolated. Phoenix100 detector was used and susceptibility testing of Pseudomonas aeruginosa resistance was analyzed. Results The number of strains of P. aeruginosa was 102, accounting for 16.92%, which was the highest detection rate of strain type. The highest resistance of Pseudomonas aeruginosa to ceftriaxone, ampicil in, ampicil in /sulbactam was al 100%. The resistance of Pseudomonas aeruginosa to Amikacin , gentamicin, tobramycin was lowest, wherein the resistance to amikacin was 0. Conclusion The resistance of Pseudomonas aeruginosa in our hospital is high. This results provides a reference for the clinical treatment of biology, but also put forward new requirements for the use of antimicrobial agents in a hospital clinic, suggesting we should be strengthen Pseudomonas aeruginosa monitoring and the hospital infection control measures in the future.